Fatal transplant-associated west nile virus encephalitis and public health investigation - California, 2010

Transplantation

Volumn 96, Issue 5, 2013, Pages 463-468

  Rabe, Ingrid B ^a   Schwartz, Brian S ^b   Farnon, Eileen C ^a   Josephson, S Andrew ^b   Webber, Allison B ^b   Roberts, John Paul ^b   De Mattos, Angelo M ^c   Gallay, Brian J ^c   Van Slyck, Sean ^d   Messenger, Sharon L ^e   Yen, Cynthia J ^e   Bloch, Evan M ^f   Drew, Clifton P ^a   Fischer, Marc ^a   Glaser, Carol A ^e  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d California Transplant Donor Network   (United States)

^e CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^f BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

Author keywords

Encephalitis; Transplant associated transmission; West Nile virus

Indexed keywords

BASILIXIMAB; CYCLOSPORIN; IMMUNOGLOBULIN G ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GRAFT INFECTION; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MEDICAL HISTORY; NUCLEIC ACID ANALYSIS; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PUBLIC HEALTH; SEROLOGY; UNITED STATES; VIREMIA; VIRUS DETECTION; VIRUS ENCEPHALITIS; VIRUS TRANSMISSION; WEST NILE VIRUS ENCEPHALITIS;

AGED; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PUBLIC HEALTH; TISSUE DONORS; WEST NILE FEVER;

EID: 84883557845     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31829b4142     Document Type: Article

References (29)

1. Lindsey NP, Staples JE, Lehman JA, et al. Surveillance for humanWest Nile virus diseaseVUnited States, 1999Y2008. MMWR Surveill Summ 2010; 59: 1
2. Campbell GL, Marfin AA, Lanciotti RS, et al. West Nile virus. Lancet Infect Dis 2002; 2: 519
3. Mostashari F, Bunning ML, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 2001; 358: 261
4. Sejvar JJ, Haddad MB, Tierney BC, et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA 2003; 290: 511
5. West Nile virus infections in organ transplant recipientsVNew York and Pennsylvania, August-September, 2005. MMWR Morb Mortal Wkly Rep 2005; 54: 1021
6. Iwamoto M, Jernigan DB, Guasch A, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003; 348: 2196
7. Pealer LN, Marfin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003; 349: 1236
8. Kumar D, Drebot MA, Wong SJ, et al. A seroprevalence study of West Nile virus infection in solid organ transplant recipients. Am J Transplant 2004; 4: 1883
9. Kumar D, Prasad GV, Zaltzman J, et al. Community-acquired West Nile virus infection in solid-organ transplant recipients. Transplantation 2004; 77: 399
10. Rhee C, Eaton EF, Concepcion W, et al. West Nile virus encephalitis acquired via liver transplantation and clinical response to intravenous immunoglobulin: case report and review of the literature. Transpl Infect Dis 2011; 13: 312
11. Nett RJ, Kuehnert MJ, Ison MG, et al. Current practices and evaluation of screening solid organ donors for West Nile virus. Transpl Infect Dis 2012; 14: 268
12. Costa AN, Capobianchi MR, Ippolito G, et al. West Nile virus: the Italian national transplant network reaction to an alert in the northeastern region, Italy 2011. Euro Surveill 2011; 16
13. Stramer SL, Fang CT, Foster GA, et al. West Nile virus among blood donors in the United States, 2003 and 2004. NEngl JMed 2005; 353: 451
14. Sioka C, Kyritsis AP. Central and peripheral nervous system toxicity of common chemotherapeutic agents. Cancer Chemother Pharmacol 2009; 63: 761
15. Morelli MC, Sambri V, Grazi GL, et al. Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. Clin Infect Dis 2010; 51: e34
16. Penn RG, Guarner J, Sejvar JJ, et al. Persistent neuroinvasiveWest Nile virus infection in an immunocompromised patient. Clin Infect Dis 2006; 42: 680
17. Ison MG, Nalesnik MA. An update on donor-derived disease transmission in organ transplantation. Am J Transplant 2011; 11: 1123
18. Price WH, Thind IS. The mechanism of cross-protection afforded by dengue virus againstWest Nile virus in hamsters. J Hyg (Lond) 1972; 70: 611
19. Mansfield KL, Horton DL, Johnson N, et al. Flavivirus-induced antibody cross-reactivity. J Gen Virol 2011; 92: 2821
20. Lobigs M, Diamond MS. Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex. Expert Rev Vaccines 2012; 11: 177
21. Busch MP, Kleinman SH, Tobler LH, et al. Virus and antibody dynamics in acute West Nile virus infection. J Infect Dis 2008; 198: 984
22. Beasley DW. Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus. Immunotherapy 2011; 3: 269
23. Kiberd BA, Forward K. Screening for West Nile virus in organ transplantation: a medical decision analysis. Am J Transplant 2004; 4: 1296
24. Lanciotti RS, Kerst AJ, Nasci RS, et al. Rapid detection of West Nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol 2000; 38: 4066
25. FDA. Summary Basis of ApprovalVProcleix\ WNVAssay, 2005
26. Hogrefe WR, Moore R, Lape-Nixon M, et al. Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus- and other flavivirus-specific antibodies. J Clin Microbiol 2004; 42: 4641
27. Johnson AJ, Cheshier RC, Cosentino G, et al. Validation of a microsphere-based immunoassay for detection of anti-West Nile virus and anti-St. Louis encephalitis virus immunoglobulin M antibodies. Clin Vaccine Immunol 2007; 14: 1084
28. Lindsey HS, Calisher CH, Mathews JH. Serum dilution neutralization test for California group virus identification and serology. J Clin Microbiol 1976; 4: 503
29. Guarner J, Shieh WJ, Hunter S, et al. Clinicopathologic study and laboratory diagnosis of 23 cases with West Nile virus encephalomyelitis. Hum Pathol 2004; 35: 983.